(203) 208-3464 info@wrenlaboratories.com
Drag · hover · click
Providers

Find the message in your patient’s blood.

By analyzing RNA from whole blood, Wren’s mRNA liquid biopsy — backed by 115+ patents and 60+ clinical studies — gives a dynamic snapshot of tumor status and future behavior, and helps predict response to therapeutics.

The power of RNA technology

A dynamic readout, not a static mutation.

RNA is a critical molecule that carries instructions from DNA to produce proteins essential for life — or tumorigenesis. Analyzing RNA from whole blood offers more precise insights than conventional methods.

Why choose Wren Laboratories mRNA testing?

  • Aid in diagnosis. Can help detect patients with and without cancer for NET and prostate cancers.
  • Predictive insights. Can aid in predicting whether a tumor is stable or progressive.
  • Monitoring post-surgery or on treatment. Can help detect minimal residual disease after surgery, or recurrence earlier than other tools.
  • Treatment decisions. Can predict tumor response to radiotherapeutics.
  • Minimally invasive. Requires just a small blood sample.
  • Proven reliability. Supported by extensive clinical investigations.
Ordering is simple

Fits straight into your workflow.

Fast online ordering

Place orders, track status and receive results in the provider portal.

Kits to your office

Collection kits shipped directly to your practice.

10-day RNA stability

Ambient sample shipping — no dry ice needed.

Dedicated project managers

Real people available to assist with every order.

What is the process?

Five steps from order to answer.

1

Submit an order

Order online or with the requisition form.

2

Receive kit

Shipped to your office or the patient’s home for mobile phlebotomy.

3

Return the sample

Blood is returned to Wren Laboratories at ambient temperature.

4

Get results

Results are available in 5–7 days and sent directly to you.

5

Get support

Call (203) 208-3464 or email info@wrenlaboratories.com.

Evidence

Supporting your decisions for cancer patients.

Trusted by 45+ top institutions and 70+ investigators worldwide — dedicated to helping providers make confident, data-driven decisions.

45+Institutions
70+Investigators
60+Clinical studies
115+Patents
Get started

Providers, order your test here

Order NETest 2.0® or PROSTest® through our portal or with the requisition form — kits ship directly to your office.